Očekávání osobního přínosu subjektu z účasti v klinickém hodnocení

Title:

Očekávání osobního přínosu subjektu z účasti v klinickém hodnocení
Očekávání osobního přínosu subjektu z účasti v klinickém hodnocení

Creator:

Norková, Olga

Contributor:

Norková, Olga

Identifier:

https://cdk.lib.cas.cz/client/handle/uuid:bmc12014880-95bb36f5-7cfb-494c-82c1-07d84d6db08b
uuid:bmc12014880-95bb36f5-7cfb-494c-82c1-07d84d6db08b
local:bmc12014880
http://www.ilaw.cas.cz/medlawjournal/index.php/medlawjournal
local: bmc12014880

Subject:

lidé, léčivé přípravky, schvalování léčiv, klinické zkoušky kontrolované - jako téma--metody--normy--využití, experimenty na lidech--etika--normy--zákonodárství a právo, vztahy mezi výzkumníkem a subjektem--etika, spokojenost pacientů, lékařská etika, altruismus, motivace, and odměna

Type:

model:article, article, Text, statistics, and TEXT

Format:

braille, electronic resource, remote, and elektronický zdroj

Description:

Participation of Human Subjects in a Clinical Trial is the fundamental part of Medical Research. Human Subject's participation depends on the willingness of the potential Subjects to volunteer in such a Clinical Trial. The Subject's motivations for the Clinical Trial participation diverse based on the different motivational factors. Patient's deciding whether to participate in a Clinical trial or not is influenced mainly by the current Patient’s health status and the possibility of the available standard therapy in the treatment of a serious or a life-threatening illness. The important role in the Patient decision process takes the close relationship Physician-Patient. There is no consensus among Scientists whether the Patient’s expected therapeutic benefit using the new medicinal product is the most motivational factor for the Clinical trial participation or not. Some of the latter research has concluded that some Patients frequently overestimate the chance of benefit from particular treatment. However the Patient's expectations of the potential therapeutic benefit do not depend on the Patient's correct understandings of the Clinical Trial purpose. The Patient’s willingness to contribute to the progress of medicine and desire to help other Patients is secondary consideration for the Clinical Trial participation which is reported in the medical journals. Especially Patients suffering from a life-threatening illness report altruistic reasons however this will not exclude them to expect the potential personal benefit as well. The indirect costs reimbursement to Patients during the Clinical Trial participation might motivate many potential participants for the Clinical Trial participation. This article sought to present the most frequent Subject's Expected Benefit from the Clinical Trial participation in the context of the Patient being engaged in Medical Research. Gaining a deeper understanding of this topic might be benefited for both Researchers and Physicians., Olga Norková, and Literatura 18

Language:

Czech and English

Rights:

http://creativecommons.org/publicdomain/mark/1.0/
policy:public

Relation:

Časopis zdravotnického práva a bioetiky--MED00175105

Source:

Časopis zdravotnického práva a bioetiky: =Journal of medical law and bioethics | 2012 Volume:2 | Number:1

Harvested from:

CDK

Metadata only:

false

Date:

2012